Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

Completed · Not applicable · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will examine possible causes of metabolic side effects in people taking atypical antipsychotic (AAP) medications.

Key facts

Study ID

NCT00815854

Run by

University of Michigan

People needed

88

Starts

2008-10-01

Expected to finish

2019-05-01

Last updated by the study team

2019-06-21

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.